Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Gyros Protein Technologies
Gyros Protein Technologies
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency
Partnership complements Gyros’ PurePep EasyClean technology offering with an automated solution for advanced discovery process
Manufacturing
Gyros Protein Technologies introduces updated peptide synthesiser
The device introduces real-time flow technology, a non-invasive method designed to continually monitor the flow rate of fluids within the system
Manufacturing
Gyros Protein Technologies introduces Gyrolab AAV9 Titer kit
The kit is designed to support AAV-based CGT production
Finance
Gyros Protein Technologies and Cygnus expand collaboration
The extension of the collaboration follows the launch of the ready-to-use Gyrolab CHO HCP and <i>E. coli</i> HCP kits, developed through a licensing and supply agreement with Cygnus
Manufacturing
Mesa Labs acquires Gyros Protein Technologies
The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin its push into biopharmaceutical development
Manufacturing
Gyros Protein Technologies introduces lentivirus titre kit
Ready-to-use kit enabled lentivirus titre determinations during the manufacture of lentivirus vectors
Manufacturing
Gyros Protein Technologies debuts test for impurities in E. coli systems
New product is a host cell protein (HCP) kit for automated impurity analysis of biotherapeutics expressed in <i>E. coli</i> systems
Subscribe now